BOLT Stock Analysis: Buy, Sell, or Hold?
BOLT - Bolt Biotherapeutics, Inc. Common Stock
$3.78
0.00 (0.00%)
▲
5d:
-5.74%
30d:
-14.67%
90d:
-23.01%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When BOLT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BOLT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BOLT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BOLT is currently trading at $3.78, which is considered oversold relative to its 30-day fair value range of $3.92 to $4.53.
Technical Outlook: Technically, BOLT is in a downtrend. The price is currently testing key support at $3.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BOLT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $41.00 (+984.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BOLT is in a downtrend. The price is currently testing key support at $3.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BOLT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $41.00 (+984.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.92 -
$4.53
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 984.7% below Wall St target ($41.00)
- CAUTION: 5-day price weakness (-5.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$3.92 -
$4.53
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.78
Resistance Level
$4.41
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.01
Wall Street Target
$41.00
(+984.7%)
Revenue Growth (YoY)
-97.9%
Share & Embed Analysis
Last updated: July 13, 2026 8:43 PM ET
Data refreshes hourly during market hours. Next update: 9:43 PM
Data refreshes hourly during market hours. Next update: 9:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
